Inclusive research in ophthalmology is mission critical! The 10-point action plan.
作者信息
Dinah Christiana, Williams Olayinka, Varma Deepali, Reynolds Rhianon, Patel Praveen J, Mulholland Padraig, Ghanchi Faruque, Bourne Rupert R A
机构信息
London North West University Healthcare NHS, London, UK.
Brain Sciences Department, Imperial College, London, UK.
出版信息
Eye (Lond). 2024 Feb;38(2):235-237. doi: 10.1038/s41433-023-02677-8. Epub 2023 Jul 24.
Abstract
摘要
相似文献
1
Inclusive research in ophthalmology is mission critical! The 10-point action plan.眼科领域的包容性研究至关重要！十点行动计划。
Eye (Lond). 2024 Feb;38(2):235-237. doi: 10.1038/s41433-023-02677-8. Epub 2023 Jul 24.
2
Nordic research in ophthalmology.北欧的眼科研究。
Acta Ophthalmol Scand. 2003 Dec;81(6):556-66. doi: 10.1111/j.1395-3907.2003.00177.x.
3
Ophthalmology: now and then.眼科：今昔
Middle East Afr J Ophthalmol. 2012 Jul-Sep;19(3):271-2. doi: 10.4103/0974-9233.97919.
4
[German research. Challenges and targets in ophthalmology].[德国研究。眼科领域的挑战与目标]
Ophthalmologe. 2008 Dec;105(12):1089. doi: 10.1007/s00347-008-1875-z.
5
[Glaucoma in China: where we are and what the future is].[中国的青光眼：现状与未来]
Zhonghua Yan Ke Za Zhi. 2015 Feb;51(2):81-3.
6
[European research promotion in Ophthalmology].[欧洲眼科研究促进]
Ophthalmologe. 2006 Jul;103(7):620. doi: 10.1007/s00347-006-1371-2.
7
Contribution of medical science in Turkey to the scientific world and the field of ophthalmology.土耳其医学对科学界及眼科学领域的贡献。
Arq Bras Oftalmol. 2017 Sep-Oct;80(5):V-VI. doi: 10.5935/0004-2749.20170067.
8
[Communications of the 101st Annual Meeting of the Swiss Society of Ophthalmology SOG/SSO, Interlaken, September 10 - 13, 2008].[瑞士眼科学会（SOG/SSO）第101届年会通讯，因特拉肯，2008年9月10日至13日]
Klin Monbl Augenheilkd. 2009 Apr;226(4):215. doi: 10.1055/s-0028-1109342. Epub 2009 Apr 21.
9
[Communications of the 104th Annual Meeting of the Swiss Society of Ophthalmology SOG/SSO, Interlaken, August 31 - September 3, 2011].[瑞士眼科学会（SOG/SSO）第104届年会通讯，因特拉肯，2011年8月31日至9月3日]
Klin Monbl Augenheilkd. 2012 Apr;229(4):305. doi: 10.1055/s-0031-1299470. Epub 2012 Apr 11.
10
[Congress debriefing].[国会汇报]
Ophthalmologe. 2009 Nov;106(11):1040-7. doi: 10.1007/s00347-009-2085-z.
引用本文的文献
1
Avacincaptad Pegol: First Approval.阿伐卡西单抗 Pegol：首次批准。
Drugs. 2023 Oct;83(15):1447-1453. doi: 10.1007/s40265-023-01948-8.
本文引用的文献
1
Action on sickle cell retinopathy: the time is now.应对镰状细胞视网膜病变：刻不容缓。
Eye (Lond). 2022 Jun;36(6):1138-1139. doi: 10.1038/s41433-021-01918-y. Epub 2022 Jan 28.
2
Revisiting NICE guidelines for initiation of intravitreal anti-VEGF therapy for centre-involving diabetic macular oedema: a survey of current interpretation in the United Kingdom.重新审视英国国家卫生与临床优化研究所（NICE）关于玻璃体内抗血管内皮生长因子（VEGF）治疗累及黄斑中心的糖尿病性黄斑水肿起始治疗的指南：对英国当前解读情况的一项调查
Eye (Lond). 2022 Sep;36(9):1832-1834. doi: 10.1038/s41433-022-01935-5. Epub 2022 Jan 25.
3
Race and ethnic representation among clinical trials for diabetic retinopathy and diabetic macular edema within the United States: A review.美国糖尿病性视网膜病变和糖尿病性黄斑水肿临床试验中的种族和族裔代表性：一项综述。
J Natl Med Assoc. 2022 Apr;114(2):123-140. doi: 10.1016/j.jnma.2021.12.016. Epub 2022 Jan 22.
4
The Intersectionality Toolbox: A Resource for Teaching and Applying an Intersectional Lens in Public Health.《交叉性工具箱：公共卫生教学与应用交叉视角的资源》
Front Public Health. 2021 Dec 2;9:772301. doi: 10.3389/fpubh.2021.772301. eCollection 2021.
5
Diversity in clinical trials: an opportunity and imperative for community engagement.临床试验中的多样性：社区参与的机遇与必要条件。
Lancet Gastroenterol Hepatol. 2021 Aug;6(8):605-607. doi: 10.1016/S2468-1253(21)00228-4.
6
Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.种族和民族在原发性开角型青光眼临床试验中的差异：系统评价和荟萃分析。
JAMA Netw Open. 2021 May 3;4(5):e218348. doi: 10.1001/jamanetworkopen.2021.8348.
7
Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014.2004-2014 年葡萄膜黑色素瘤的治疗和生存与种族、民族和社会经济因素的相关性评估。
JAMA Ophthalmol. 2020 Aug 1;138(8):876-884. doi: 10.1001/jamaophthalmol.2020.2254.
8
Future burden of vision loss in Australia: Projections from the National Eye Health Survey.未来澳大利亚视力丧失的负担：国家眼健康调查的预测。
Clin Exp Ophthalmol. 2020 Aug;48(6):730-738. doi: 10.1111/ceo.13776. Epub 2020 May 18.
9
Evaluating Whether Sight Is the Most Valued Sense.评估视觉是否是最有价值的感官。
JAMA Ophthalmol. 2019 Nov 1;137(11):1317-1320. doi: 10.1001/jamaophthalmol.2019.3537.
10
Increasing Diversity in Clinical Trials: Overcoming Critical Barriers.提高临床试验的多样性：克服关键障碍。
Curr Probl Cardiol. 2019 May;44(5):148-172. doi: 10.1016/j.cpcardiol.2018.11.002. Epub 2018 Nov 9.
Zotero 插件